WallStreetZenWallStreetZen

NASDAQ: ABSI
Absci Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for ABSI

Based on 5 analysts offering 12 month price targets for Absci Corp.
Min Forecast
$6.00+63.49%
Avg Forecast
$8.40+128.88%
Max Forecast
$13.00+254.22%

Should I buy or sell ABSI stock?

Based on 5 analysts offering ratings for Absci Corp.
Strong Buy
Strong Buy
3 analysts 60%
Buy
2 analysts 40%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ABSI stock forecasts and price targets.

ABSI stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-08-15
lockedlocked$00.00+00.00%2024-07-11
lockedlocked$00.00+00.00%2024-07-03
lockedlocked$00.00+00.00%2024-03-26
lockedlocked$00.00+00.00%2024-03-14

1 of 1

Forecast return on equity

Is ABSI forecast to generate an efficient return?
Company
-5.38%
Industry
-402.71%
Market
58.16%
ABSI's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ABSI forecast to generate an efficient return on assets?
Company
-4.67%
Industry
26.38%
ABSI is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ABSI earnings per share forecast

What is ABSI's earnings per share in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
-$0.80
Avg 2 year Forecast
-$0.61
Avg 3 year Forecast
-$0.23

ABSI revenue forecast

What is ABSI's revenue in the next 3 years based on estimates from 6 analysts?
Avg 1 year Forecast
$6.9M+112.95%
Avg 2 year Forecast
$22.1M+578.58%
Avg 3 year Forecast
$68.1M+1,996.77%
ABSI's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ABSI revenue growth forecast

How is ABSI forecast to perform vs Biotechnology companies and vs the US market?
Company
163.26%
Industry
34.75%
Market
9.32%
ABSI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ABSI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ABSI vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ABSI$3.67$8.40+128.88%Strong Buy
GHRS$8.01$36.67+357.77%Strong Buy
OPT$3.06$12.00+292.16%Buy
MNMD$5.84$30.00+413.70%Buy
AVXL$5.01$43.00+759.14%Strong Buy
View Top Biotech Stocks

Absci Stock Forecast FAQ

Is Absci Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NASDAQ: ABSI) stock is to Strong Buy ABSI stock.

Out of 5 analysts, 3 (60%) are recommending ABSI as a Strong Buy, 2 (40%) are recommending ABSI as a Buy, 0 (0%) are recommending ABSI as a Hold, 0 (0%) are recommending ABSI as a Sell, and 0 (0%) are recommending ABSI as a Strong Sell.

If you're new to stock investing, here's how to buy Absci stock.

What is ABSI's earnings growth forecast for 2024-2026?

(NASDAQ: ABSI) Absci's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 15.16%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 16.98%.

Absci's earnings in 2024 is -$92,264,000.On average, 3 Wall Street analysts forecast ABSI's earnings for 2024 to be -$90,470,331, with the lowest ABSI earnings forecast at -$96,522,884, and the highest ABSI earnings forecast at -$85,167,251. On average, 4 Wall Street analysts forecast ABSI's earnings for 2025 to be -$68,985,473, with the lowest ABSI earnings forecast at -$91,980,631, and the highest ABSI earnings forecast at -$43,151,407.

In 2026, ABSI is forecast to generate -$25,743,221 in earnings, with the lowest earnings forecast at -$39,744,717 and the highest earnings forecast at -$11,355,633.

What is ABSI's revenue growth forecast for 2024-2026?

(NASDAQ: ABSI) Absci's forecast annual revenue growth rate of 163.26% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 34.75%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.32%.

Absci's revenue in 2024 is $3,250,000.On average, 6 Wall Street analysts forecast ABSI's revenue for 2024 to be $785,923,388, with the lowest ABSI revenue forecast at $567,781,670, and the highest ABSI revenue forecast at $1,044,718,273. On average, 6 Wall Street analysts forecast ABSI's revenue for 2025 to be $2,504,371,390, with the lowest ABSI revenue forecast at $1,362,676,008, and the highest ABSI revenue forecast at $6,115,008,586.

In 2026, ABSI is forecast to generate $7,738,296,380 in revenue, with the lowest revenue forecast at $5,564,260,366 and the highest revenue forecast at $9,297,424,846.

What is ABSI's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: ABSI) forecast ROA is -4.67%, which is lower than the forecast US Biotechnology industry average of 26.38%.

What is ABSI's Price Target?

According to 5 Wall Street analysts that have issued a 1 year ABSI price target, the average ABSI price target is $8.40, with the highest ABSI stock price forecast at $13.00 and the lowest ABSI stock price forecast at $6.00.

On average, Wall Street analysts predict that Absci's share price could reach $8.40 by Aug 15, 2025. The average Absci stock price prediction forecasts a potential upside of 128.88% from the current ABSI share price of $3.67.

What is ABSI's Earnings Per Share (EPS) forecast for 2024-2026?

(NASDAQ: ABSI) Absci's current Earnings Per Share (EPS) is -$0.93. On average, analysts forecast that ABSI's EPS will be -$0.80 for 2024, with the lowest EPS forecast at -$0.85, and the highest EPS forecast at -$0.75. On average, analysts forecast that ABSI's EPS will be -$0.61 for 2025, with the lowest EPS forecast at -$0.81, and the highest EPS forecast at -$0.38. In 2026, ABSI's EPS is forecast to hit -$0.23 (min: -$0.35, max: -$0.10).

What is ABSI's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: ABSI) forecast ROE is -5.38%, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.